Technical Analysis for EVLO - Evelo Biosciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 10.58 | -9.03% | -1.05 |
EVLO closed down 3.57 percent on Tuesday, March 2, 2021, on 51 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Historical EVLO trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | -7.27% | |
Wide Bands | Range Expansion | -7.27% | |
Down 3 Days in a Row | Weakness | -7.27% | |
Down 4 Days in a Row | Weakness | -7.27% | |
Lower Bollinger Band Touch | Weakness | -7.27% | |
Oversold Stochastic | Weakness | -7.27% | |
Lower Bollinger Band Walk | Weakness | -10.57% | |
Wide Bands | Range Expansion | -10.57% | |
Below Lower BB | Weakness | -10.57% | |
Down 3 Days in a Row | Weakness | -10.57% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
60 Minute Opening Range Breakdown | 34 minutes ago | |
Fell Below Lower Bollinger Band | about 6 hours ago | |
Down 5% | about 6 hours ago | |
Down 3% | about 6 hours ago | |
Down 2 % | about 6 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/09/2021
Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Inflammatory Disease Inflammatory Diseases Treatment For Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Inflammatory Disease Inflammatory Diseases Treatment For Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 19.9283 |
52 Week Low | 3.01 |
Average Volume | 314,831 |
200-Day Moving Average | 7.10 |
50-Day Moving Average | 14.18 |
20-Day Moving Average | 15.21 |
10-Day Moving Average | 13.69 |
Average True Range | 1.44 |
ADX | 30.45 |
+DI | 14.67 |
-DI | 27.81 |
Chandelier Exit (Long, 3 ATRs ) | 14.46 |
Chandelier Exit (Short, 3 ATRs ) | 15.77 |
Upper Bollinger Band | 18.87 |
Lower Bollinger Band | 11.56 |
Percent B (%b) | 0.01 |
BandWidth | 48.01 |
MACD Line | -0.59 |
MACD Signal Line | 0.05 |
MACD Histogram | -0.6443 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 13.30 | ||||
Resistance 3 (R3) | 13.42 | 12.99 | 13.02 | ||
Resistance 2 (R2) | 12.99 | 12.56 | 12.93 | 12.93 | |
Resistance 1 (R1) | 12.31 | 12.30 | 12.09 | 12.19 | 12.84 |
Pivot Point | 11.87 | 11.87 | 11.77 | 11.81 | 11.87 |
Support 1 (S1) | 11.20 | 11.45 | 10.98 | 11.07 | 10.42 |
Support 2 (S2) | 10.76 | 11.19 | 10.70 | 10.33 | |
Support 3 (S3) | 10.08 | 10.76 | 10.24 | ||
Support 4 (S4) | 9.96 |